PedAM
Pediatric Disease Annotations & Medicines
| Disease | lymphoma |
| Phenotype | C0242379|lung cancer |
| Sentences | 15 |
| PubMedID- 25903198 | Moreover, we observed enrichment for b-cell and oncogenic related pathways (for example, the b-cell receptor signaling pathway, small cell lung cancer, regulation of b-cell proliferation, lymphoma and leukemia) as shown in figure 5 and additional file 2. taken together, these results highlight that apoptotic genes, and oncogenic processes in general, are frequently targeted by mutations within tfbss found at their promoter regions.figure 5functional enrichment analyses of genes associated with frequently mutated regions. |
| PubMedID- 22465695 | Fluorescence in situ hybridization (fish) is currently used to detect non-small cell lung cancer (nsclc) patients with anaplastic lymphoma kinase (alk) gene rearrangement, who are candidates for alk inhibitor therapy. |
| PubMedID- 25170012 | Fda approval summary: crizotinib for the treatment of metastatic non-small cell lung cancer with anaplastic lymphoma kinase rearrangements. |
| PubMedID- 25257756 | Cell block samples from malignant pleural effusion might be valid alternative samples for anaplastic lymphoma kinase detection in patients with advanced non-small-cell lung cancer. |
| PubMedID- 23618692 | Aims: in lung cancer with anaplastic lymphoma kinase (alk) gene rearrangement, accurate diagnosis is essential to identify patients who can be treated with a specific kinase inhibitor. |
| PubMedID- 23524472 | Primary lung cancer complicated by malignant lymphoma in two cases of epstein-barr virus infection. |
| PubMedID- 23618014 | Conclusions: compared to the normal population, second primary malignancy (in particular leukaemia and lung cancer) in patients with malignant lymphoma during their long-term survival has been seen occasionally. |
| PubMedID- 25624888 | A case of primary lung cancer complicated by lymphoma was described by ohno et al (9). |
| PubMedID- 21490772 | This review will focus on current knowledge of the beneficial effects of hdl-cholesterol as it relates to cardiovascular diseases, breast and lung cancers, non-hodgkin's lymphoma, as well as its neuroprotective potential in reducing the risk of alzheimer's disease and dementia. |
| PubMedID- 24885608 | Background: the discovery of the fusion gene echinodermmicro tubule associated proteinlike 4-anaplastic lymphoma kinase, eml4-alk, in patients with non-small-cell lung cancer has led to the remarkable development of anaplastic lymphoma kinase inhibitors, such as crizotinib. |
| PubMedID- 22295164 | Variables affecting survival after second primary lung cancer: a population-based study of 187 hodgkin's lymphoma patients. |
| PubMedID- 25682546 | Background: there have been conflicting findings regarding the efficacy of pemetrexed for lung cancer with anaplastic lymphoma kinase (alk) rearrangement. |
| PubMedID- 25676399 | Background: besides epidermal growth factor receptor (egfr) mutation, the non-small cell lung cancer (nsclc) of anaplastic lymphoma kinase (alk) rearrangement becomes another important clinical subtype. |
| PubMedID- 21692074 | Survival after second primary lung cancer: a population-based study of 187 hodgkin lymphoma patients. |
| PubMedID- 20609777 | We matched lymphoma patients with lung cancer patients who had no lymphoma based on age, gender, surgery type, comorbidities, stage, and histology. |
Page: 1